<record>
  <isbns></isbns>
  <shortDBName>cmedm</shortDBName>
  <isiType>JOUR</isiType>
  <notes></notes>
  <mid></mid>
  <language>eng</language>
  <source>BMC cancer</source>
  <bookEdition></bookEdition>
  <title>Enhancing prediction and stratifying risk: machine learning and bayesian-learning models for catheter-related thrombosis in chemotherapy patients.</title>
  <pageEnd></pageEnd>
  <pageStart>552</pageStart>
  <peerReviewed>true</peerReviewed>
  <isOpenAccess></isOpenAccess>
  <publicationDate>20250327</publicationDate>
  <pageCount></pageCount>
  <publisherLocations>England</publisherLocations>
  <issue>1</issue>
  <identifiers></identifiers>
  <subjects>Bayes Theorem ; Machine Learning ; Breast Neoplasms drug therapy ; Humans ; Female ; Middle Aged ; Risk Assessment methods ; Adult ; Risk Factors ; Central Venous Catheters adverse effects ; Thrombosis etiology ; Thrombosis epidemiology ; Aged ; Catheterization, Central Venous adverse effects ; Antineoplastic Agents adverse effects ; Antineoplastic Agents therapeutic use ; ROC Curve ; Retrospective Studies ; Proportional Hazards Models</subjects>
  <abstract>Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval number: 22/444â€“3646). As this research involved a retrospective analysis of previously collected data, the requirement for informed consent was waived by the committee. The ethics committee also waived the need for consent to participate in the study. All data were de-identified to maintain patient confidentiality and privacy. The retrospective nature of the study ensured that there was no direct contact with patients, and no additional risks were posed to individuals whose data were included in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</abstract>
  <pubTypes>Journal Article ; Academic Journal</pubTypes>
  <an>40148861</an>
  <docTypes>Journal Article</docTypes>
  <volume>25</volume>
  <issns>1471-2407 ; Electronic</issns>
  <degreeLevel></degreeLevel>
  <plink>https://research.ebsco.com/linkprocessor/plink?id=c3c1d990-27bc-35be-bb78-f68aa9075d6a</plink>
  <doids></doids>
  <publisher>BioMed Central</publisher>
  <contributors>An, Tao ; Han, Han ; Xie, Junying ; Wang, Yifan ; Zhao, Yiqi ; Jia, Hao ; Wang, Yanfeng</contributors>
  <coverDate>2025 Mar 27</coverDate>
  <longDBName>MEDLINE</longDBName>
  <doi>10.1186/s12885-025-13946-y</doi>
</record>
